ACT Genomics Hong Kong

ACT Genomics HK office has begun its operation in January 2017. Our managing director, Eddie Liu strives to provide not only cancer genetic testing, but also comprehensive cancer treatment plan as a service to the cancer patients and physicians of great need in Hong Kong.
In Hong Kong, there were 29,618 new cancer cases diagnosed in 2014, which increased 2.4% compared with 2013 according to the Hong Kong Cancer Registry. The most common cancer types are colorectal (16.8%), lung (15.8%), breast (13.1%), liver (6.2%) and prostate (5.8%).
We aim to transform cancer treatment to satisfy the growing cancer needs in Hong Kong. Therefore, we opened our Hong Kong office to serve and provide comprehensive genomic-guided cancer treatment plan.

Recent Events

2017.09.21 Precision Oncology Symposium Session III: Lung Cancer

Precision Oncology Symposium Session III: Lung Cancer was held on September 21, 2017 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong Lung Cancer Study Group (HKLCSG), and sponsored by ACT Genomics.






Full Version - 2017 Precision Oncology Symposium - Lung Cancer - Hong Kong

Dr. Jacky Yu-Chung Li on "Go Beyond Resistance"

Dr. Shu Jen Chen on "Clinical Application of NGS on Lung Cancer Management"

Q&A Session - Lung Cancer

2017.06.15 Precision Oncology Symposium Session II: Colorectal Cancer

Precision Oncology Symposium Session II: Colorectal Cancer was held on June 15, 2017 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong College Of Radiologists and Hong Kong Society of Clinical Oncology, and sponsored by ACT Genomics.








2017 Precision Oncology Symposium - Colorectal Cancer in Hong Kong

Dr. Chi Leung Chiang on "Management of Metastatic Colorectal Cancer (mCRC)"

Dr. Siu-Kie Au on "Molecular Classification of Colorectal Cancer"

Dr. Jensen Poon on "Surgical Management of Colorectal Cancer"

Dr. Shu Jen Chen on "NGS and Precision Management of Colorectal Cancer"

Q&A Session - Colorectal Cancer


2017.05.10 Precision Oncology Symposium Session I: Breast Cancer

Hosted by the Hong Kong Breast Oncology Group and ACT Genomics, Precision Oncology Symposium Session I: Breast Cancer was held on May 10, 2017 and featured a series of presentations by experts in the field.








Event Highlights of Breast Cancer Precision Oncology Symposium

Dr. Lorraine Chow on "Surgical Management of Breast Cancer"

Dr. Joseph Au on "Genomics Assay and Adjuvant Treatment Decision-Making"

Dr. Janice Tsang on "Targeted Therapies for Breast Cancer"

Dr. Shu Jen Chen on "NGS Application for Management of Breast Cancer"

Welcome to ACT Genomics Hong Kong

Contact

To find out more about our services, get in touch with us at

ACT Genomics Hong Kong

Office: Unit 1001, 10F., Miramar Tower, 132 Nathan Road, Tsim Sha Tsui, Kowloon, Hong Kong

We look forward to hearing from you .